Anti-JC virus antibodies: implications for PML risk stratification.
Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M.
Gorelik L, et al. Among authors: berman m.
Ann Neurol. 2010 Sep;68(3):295-303. doi: 10.1002/ana.22128.
Ann Neurol. 2010.
PMID: 20737510